Sign in to continue:

Wednesday, July 29th, 2026

RH Q1 2026 10-Q Report: Financial Statements, Earnings, and Key Filings Overview

RH Reports Q1 2026 Results: Key Financial Highlights and Shareholder Updates

RH Reports First Quarter 2026 Results: Key Highlights for Investors

Overview

RH (formerly Restoration Hardware) has released its unaudited financial results for the first quarter ended May 2, 2026. The report contains several updates that are vital for shareholders and may have implications for the company’s share price.

Key Financial Highlights

  • Net Income: The company reported a net loss of \$13.7 million for Q1 2026, a reversal compared to a net income of \$8.0 million in Q1 2025.
  • Net Revenue: Q1 2026 net revenues came in at \$726.1 million, reflecting a decline from the prior year period.
  • Gross Profit: Gross profit for the quarter was \$331.3 million, down from \$355.3 million in the same quarter last year.
  • Operating Loss: Operating loss for the quarter was \$11.6 million, compared to an operating income of \$3.7 million in Q1 2025.
  • Interest Expense: Interest expense remained significant at \$52.7 million for the quarter.
  • Earnings Per Share (EPS): Basic and diluted net loss per share was (\$0.73) for Q1 2026, compared to basic and diluted EPS of \$0.43 for Q1 2025.
  • Weighted-Average Shares Outstanding: The weighted-average shares used in computing EPS were 18,845,313 for Q1 2026.
  • Cash & Cash Equivalents: As of May 2, 2026, the company reported cash and cash equivalents of \$53.8 million.
  • Total Assets: The company ended the quarter with total assets of \$4.95 billion.
  • Total Liabilities: Total liabilities as of May 2, 2026, were \$4.89 billion.
  • Stockholders’ Equity: Stockholders’ equity stood at \$56.9 million, a notable decrease from \$60.6 million as of January 31, 2026.

Potential Price Sensitive Items

  • Negative Earnings: The net loss and negative EPS for the quarter may weigh on investor sentiment and could put downward pressure on the share price, especially given the year-on-year reversal from profitability.
  • Shrinking Equity Base: RH’s stockholders’ equity has dropped sharply to \$56.9 million, indicating ongoing pressure on the balance sheet. Should this trend continue, it could raise concerns about the company’s financial flexibility.
  • High Interest Expenses: The persistent high interest expense (over \$52 million for the quarter) continues to be a drag on the company’s bottom line and is a risk factor for future profitability.
  • Liquidity Watch: Cash and cash equivalents are relatively low at \$53.8 million compared to the scale of the business and liabilities, highlighting the importance of liquidity monitoring for shareholders.
  • Outstanding Shares: As of June 5, 2026, the company had 18,900,969 shares of common stock outstanding.
  • No Preferred Stock Outstanding: There were no preferred shares issued or outstanding, meaning common shareholders are not subordinate to preferred equity holders at this time.

Other Notable Details

  • Exchange: RH’s common stock is listed on the New York Stock Exchange.
  • Regulatory Filings: The company affirmed it is current in its SEC filings and has submitted all required Interactive Data Files.
  • Shareholder Structure: The company is neither a shell company nor an emerging growth company, and it is not using extended transition periods for new accounting standards.

What Shareholders Need to Know

The quarterly report for RH reveals a challenging financial period marked by a return to net losses and continued pressure from high interest expenses and declining equity. The liquidity position, though adequate for the short term, requires ongoing monitoring given the company’s significant liabilities. With no preferred stock issued, common shareholders retain full equity claims, but the shrinking equity base could be a growing concern. These results are likely to be closely watched by investors and could impact the company’s valuation in the near term.

Disclaimer

This article is for informational purposes only and is not financial advice or a recommendation to buy or sell any security. Investors should perform their own due diligence and consult with their financial advisors before making investment decisions. The information herein is based on the most recent quarterly report filed by RH for the period ended May 2, 2026.


View RH Historical chart here



Artelo Biosciences, Inc. Announces At The Market Offering Agreement With H.C. Wainwright & Co

Artelo Biosciences, Inc. Announces At The Market Offering Ag...

Azitra, Inc. Q1 2024 Financial Report: Operating Expenses, Net Loss, and Key Disclosures

Azitra, Inc. Q1 2026 Financial Report - Investor Analysis ...